Skip to content

CONTRIBUTORS

Steven Kornfeld, CFA

Partner, Private Investing

Ryan Biggs, CFA

Co-Head, Private Investing

James Cross, CFA

Co-Head of Private Investing

Robert Stevenson, CFA

Co-Head of Private Investing

Emily McCarthy

Research Associate

Executive Summary

  • The combination of massive demand, persistent inefficiencies and accelerating innovation is creating a compelling opportunity for health care technology investors.
  • Artificial intelligence (AI) is transforming health care by improving productivity, enabling continuous and personalized care, and supporting business models that align incentives around better outcomes.
  • We believe the greatest investment opportunities will emerge from companies that can break the traditional trade-off between cost, access and quality.
  • Franklin Venture Partners focuses on late-stage companies where proven execution translates innovative technologies into scalable business models and durable competitive advantages.
     

Understanding the Health Care Technology Opportunity

Health care has traditionally been viewed as a defensive sector, supported by resilient demand across economic cycles. Today, a convergence of structural and technological forces is expanding the investment narrative. Demographic trends are driving massive demand for care, while longstanding inefficiencies are creating significant opportunities for innovation. Advances in AI are enabling new business models with the potential to improve outcomes, expand access and reduce costs. Collectively, these dynamics are transforming health care from a defensive category into a structural growth market and creating a compelling opportunity for health care technology investors.

Exhibit 1: Health Care Is Moving from a Defensive Category into a Growth Market

Structural Changes in the Health care Industry

Source: Franklin Venture Partners. Views subject to change.

The convergence of structural demand, persistent inefficiencies and advances in technology is creating new opportunities to transform the US health care system. We believe the greatest opportunities will emerge from companies that break the industry’s traditional trade-offs by improving outcomes, expanding access and lowering costs while demonstrating the evidence, adoption and scalability needed to become enduring businesses. By focusing on these characteristics, Franklin Venture Partners seeks to identify and support the technology leaders shaping the future of health care.

WHAT ARE THE RISKS?

All investments involve risks, including possible loss of principal.

Equity securities are subject to price fluctuation and possible loss of principal.

Investment strategies which incorporate the identification of thematic investment opportunities, and their performance, may be negatively impacted if the investment manager does not correctly identify such opportunities or if the theme develops in an unexpected manner. Focusing investments in the health care, information technology (IT) and/or technology-related industries carries much greater risks of adverse developments and price movements in such industries than a strategy that invests in a wider variety of industries.

Investment strategies involving Private Markets (such as Private Credit, Private Equity and Real Estate) are complex and speculative, entail significant risk and should not be considered a complete investment program. Such investments should be viewed as illiquid and may require a long-term commitment with no certainty of return. Depending on the product invested in, such investments and strategies may provide for only limited liquidity and are suitable only for persons who can afford to lose the entire amount of their investment. Private investments present certain challenges and involve incremental risks as opposed to investments in public companies, such as dealing with the lack of available information about these companies as well as their general lack of liquidity. There also can be no assurance that companies will list their securities on a securities exchange, as such, the lack of an established, liquid secondary market for some investments may have an adverse effect on the market value of those investments and on an investor's ability to dispose of them at a favorable time or price.

WF: 12048660

Important Legal Information

This document is for information only and does not constitute investment advice or a recommendation and was prepared without regard to the specific objectives, financial situation or needs of any particular person who may receive it. This document may not be reproduced, distributed or published without prior written permission from Franklin Templeton.

Any research and analysis contained in this document has been procured by Franklin Templeton for its own purposes and may be acted upon in that connection and, as such, is provided to you incidentally. Although information has been obtained from sources that Franklin Templeton believes to be reliable, no guarantee can be given as to its accuracy and such information may be incomplete or condensed and may be subject to change at any time without notice. Any views expressed are the views of the fund manager as of the date of this document and do not constitute investment advice. The underlying assumptions and these views are subject to change based on market and other conditions and may differ from other portfolio managers or of the firm as a whole. 

There is no assurance that any prediction, projection or forecast on the economy, stock market, bond market or the economic trends of the markets will be realized. Franklin Templeton accepts no liability whatsoever for any direct or indirect consequential loss arising from the use of any information, opinion or estimate herein.

The value of investments and the income from them can go down as well as up and you may not get back the full amount that you invested. Past performance is not necessarily indicative nor a guarantee of future performance.

Issued by Templeton Asset Management Ltd. Registration Number (UEN) 199205211E.

CFA® and Chartered Financial Analyst® are trademarks owned by CFA Institute.